AmoyDx, AstraZeneca partner for multiple companion diagnostics
Under the agreement, AmoyDx and AstraZeneca will develop CDx for the identification of ovarian, breast, prostate and pancreatic…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Apr 22
Under the agreement, AmoyDx and AstraZeneca will develop CDx for the identification of ovarian, breast, prostate and pancreatic…
19 Apr 22
The automated AI system is intended for the early diagnosis of diabetic retinopathy (DR), age-related macular degeneration (AMD),…
18 Apr 22
InspectIR Covid-19 Breathalyser is designed for use in doctor’s offices, hospitals and mobile testing sites using a compact…
18 Apr 22
The HD-550 equipment has chromoendoscopy SFI and VIST light modes for easy detection, demarcation, and characterisation of the…
18 Apr 22
The test is equipped with high sensitivity and specificity, strong anti-interference ability and no cross-reactivity for easy operability…
18 Apr 22
Dolphin Medical Imaging is a California medical device company that develops and integrates proprietary software into point-of-care ultrasound…
14 Apr 22
The test will facilitate efficient and customised Covid-19 assessments by detecting if a patient has antibodies from a…
14 Apr 22
The portable device will be used to monitor blood ammonia in liver disease patients to help detect hepatic…
13 Apr 22
Developed in collaboration with Brainlab, Stimview XT offers real-time, 3D visualisation and stimulation of brain anatomy for deep…
13 Apr 22
With this acquisition, bioMérieux expects to further develop its global leadership in clinical microbiology